8-KMaterial AgreementsExhibits & Filings

JPMORGAN CHASE & CO 8-K Report, Material Agreement (Nov 23, 2005)

Filed November 23, 2005For Securities:JPMJPM-PCJPM-PDJPM-PKJPM-PLJPM-PMJPM-PJAMJBVYLD

Summary

This 8-K filing from JPMorgan Chase & Co. (JPM) on November 23, 2005, details the approval and subsequent granting of Stock Appreciation Rights (SARs) to key executive officers. On October 18, 2005, the Compensation & Management Development Committee approved the awards, with grants officially issued on October 20, 2005. These SARs are a form of equity compensation designed to incentivize executive performance and align their interests with shareholders. The SARs have a grant price of $34.78 per share and are exercisable in tranches over three, four, and five years from the grant date, with a ten-year termination period. The settlement of these SARs will be in JPMC common stock. Investors should note that this filing provides transparency into the company's executive compensation strategy and potential future dilution from stock issuances upon exercise of these rights.

Key Highlights

  • 1JPMorgan Chase & Co. granted Stock Appreciation Rights (SARs) to 14 executive officers.
  • 2The SARs were approved by the Compensation & Management Development Committee on October 18, 2005, and granted on October 20, 2005.
  • 3The grant price for these SARs is $34.78 per share, based on the average of the high and low stock prices on the grant date.
  • 4The SARs vest in three equal installments on the third, fourth, and fifth anniversaries of the grant date.
  • 5These SARs are settled in shares of JPMC common stock.
  • 6The SARs have a ten-year term, expiring on October 20, 2015.
  • 7Separate Form 4 filings detailing these awards were made on October 24, 2005.

Frequently Asked Questions

Stock Appreciation Rights (SARs) are a form of equity compensation that gives the holder the right to receive the increase in value of a company's stock between the grant date and the exercise date. They are granted to align the interests of executives with those of shareholders by providing them with a financial stake in the company's stock performance. In this case, they were granted to key executive officers of JPMorgan Chase & Co. as an incentive.

When these SARs are exercised, JPMC will issue new shares of common stock to settle them. This issuance can lead to dilution of existing shareholders' ownership percentage if not managed carefully. The financial impact will depend on the stock price at the time of exercise relative to the grant price of $34.78. If the stock price is above $34.78, the executives will profit, and the company will incur a cost.

The SARs become exercisable in stages: one-third of the total grant vests on the third anniversary of the grant date (October 20, 2008), another third on the fourth anniversary (October 20, 2009), and the final third on the fifth anniversary (October 20, 2010). The SARs will expire and terminate on October 20, 2015.